Azelastine hydrochloride + Fluticasone propionate
Allerduo nasal spray contains two active substances: azelastine hydrochloride and fluticasone propionate.
Allerduo nasal spray is used to relieve symptoms of moderate to severe seasonal and perennial allergic rhinitis, if the use of a single nasal antihistamine or corticosteroid is not considered sufficient.
Seasonal and perennial allergic rhinitis is an allergic reaction to substances such as plant pollen (hay fever), house dust mites, molds, dust, or pet dander.
Allerduo nasal spray relieves allergy symptoms, such as: runny nose, postnasal drip, sneezing, itching, and stuffy nose.
Before starting treatment with Allerduo nasal spray, the patient should discuss it with their doctor or pharmacist:
In these cases, the doctor will decide whether Allerduo nasal spray can be used.
It is essential to take the medicine in the dose prescribed below in section 3 or as advised by the doctor.
Taking nasal corticosteroids in higher doses than recommended may lead to adrenal gland problems, which can cause weight loss, fatigue, muscle weakness, low blood sugar, increased salt requirements, joint pain, depression, and darker skin pigmentation.
In such cases, the doctor may prescribe another medicine during periods of stress or scheduled surgery.
To avoid adrenal gland problems, the doctor may prescribe the medicine in the smallest dose that will continue to effectively control the symptoms of allergic rhinitis.
Long-term use of nasal corticosteroids (such as Allerduo nasal spray) may slow down growth in children and adolescents.
The doctor will regularly check the child's growth and ensure that they are taking the smallest effective dose.
If the patient experiences blurred vision or other vision problems, they should contact their doctor.
In case of any doubts about whether any of the above situations apply to the patient, they should consult their doctor or pharmacist before starting treatment with Allerduo nasal spray.
This medicine is not recommended for children under 12 years of age.
The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken, or might take, including those obtained without a prescription.
Some medicines may increase the effects of Allerduo nasal spray, and the doctor may recommend close monitoring if the patient is taking such medicines (including certain HIV medicines: ritonavir, cobicistat, and antifungal medicines: ketoconazole).
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Allerduo nasal spray has a negligible influence on the ability to drive and use machines.
Rarely, fatigue and dizziness may occur, which may be caused by the disease itself or the use of Allerduo nasal spray.
In such cases, the patient should not drive or operate machinery.
They should be aware that drinking alcohol may increase these effects.
This medicine contains 14 micrograms of benzalkonium chloride per actuation, which corresponds to 0.014 mg/0.14 g.
Benzalkonium chloride may cause irritation or swelling inside the nose, especially if used for a long time.
If the patient experiences discomfort during use, they should tell their doctor or pharmacist.
This medicine contains less than 1 mmol of sodium (23 mg) per actuation, which means the medicine is considered "sodium-free".
This medicine should always be used as directed by the doctor.
In case of doubts, the patient should consult their doctor or pharmacist.
To get the most benefit from the treatment, Allerduo nasal spray must be used regularly.
The patient should avoid contact with the eyes.
Nasal administration.
The patient should carefully read the instructions below and use the medicine only as directed.
Figure 1
Figure 2
Figure 3
Figure 4
It is essential to use the dose prescribed by the doctor.
Allerduo nasal spray may be used for a long time.
The duration of treatment should correspond to the period during which allergy symptoms occur.
In case of using too much nasal spray, there is a small risk of complications.
The patient should consult their doctor if they are concerned or have been taking a higher dose than recommended for a long time.
If someone, especially a child, accidentally swallows Allerduo nasal spray, they should immediately contact a doctor or the nearest hospital emergency department.
The patient should use the nasal spray as soon as they remember and then use the next dose at the usual time.
They should not use a double dose to make up for a missed dose.
The patient should not stop using Allerduo nasal spray without consulting their doctor, due to the risk of reduced treatment effectiveness.
In case of any further doubts about using this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In case of using the medicine in high doses for a long time, systemic side effects (affecting the whole body) may occur.
The risk of these side effects is much lower when using nasal corticosteroids than when using oral corticosteroids.
These side effects may vary from patient to patient and may depend on the specific corticosteroid medicine used (see section 2).
Nasal corticosteroids may affect the normal production of hormones in the body, especially when used for a long time in high doses.
In children and adolescents, these side effects may cause growth retardation.
Rarely, cases of decreased bone density (osteoporosis) have been observed when corticosteroids were used nasally for a long time.
If the patient experiences any side effects, including those not listed in the leaflet, they should tell their doctor or pharmacist.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C,
02-222 Warsaw,
phone: +48 22 49 21 301,
fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the label and carton after "EXP".
The expiry date refers to the last day of the month stated.
Do not store in the refrigerator or freeze.
Shelf life after first opening the bottle: the unused medicine should be discarded 6 months after first opening the nasal spray.
Medicines should not be disposed of via wastewater or household waste.
The patient should ask their pharmacist how to dispose of medicines that are no longer needed.
This will help protect the environment.
The active substances of the medicine are azelastine hydrochloride and fluticasone propionate.
Each gram of suspension contains 1000 micrograms of azelastine hydrochloride and 365 micrograms of fluticasone propionate.
After each actuation (0.14 g), 137 micrograms of azelastine hydrochloride (= 125 micrograms of azelastine) and 50 micrograms of fluticasone propionate are released.
The other ingredients are glycerol, microcrystalline cellulose, sodium carmellose, disodium edetate, polysorbate 80, benzalkonium chloride, phenylethyl alcohol, and purified water.
Allerduo nasal spray is a white, homogeneous suspension.
Allerduo nasal spray is available in a brown glass bottle with a pump spray, applicator, and cap.
The 25 ml bottle contains 23 g of nasal spray suspension (at least 120 doses).
Allerduo nasal spray is available in:
Not all pack sizes may be marketed.
STADA Arzneimittel AG
Stadastrasse 2-18
61118 Bad Vilbel
Germany
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:
Stada Pharm Sp. z o.o.
ul. Krakowiaków 44
02-255 Warsaw
Phone: +48 22 737 79 20
ELPEN Pharmaceutical Co. Inc.
95 Marathonos Avenue
19009 Pikermi, Attiki
Greece
STADA Arzneimittel AG
Stadastrasse 2-18
61118 Bad Vilbel
Germany
Clonmel Healthcare Limited
3 Waterford Road
Clonmel
Co. Tipperary
E91 D768
Ireland
Czech Republic:
Salvera/Tenera/Aiunera
Denmark:
Azelastine/Fluticasone STADA
Finland:
Azelastine/Fluticasone STADA
France:
Azelastine hydrochloride / Propionate de Fluticasone EG 137 micrograms/50 micrograms, suspension pour pulvérisation nasale
Ireland:
Nasorinit 137 micrograms/50 micrograms per actuation, nasal spray suspension
Netherlands:
Azelastine/Fluticasonpropionaat CF 137 microgram/50 microgram per verstuiving, neusspray, suspensie
Germany:
Azelastin/Fluticason AL Nasenspray 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension
Norway:
Azelastine/Fluticasone STADA
Poland:
Allerduo
Slovakia:
Azelastín/Flutikazón STADA
Sweden:
Azelastine/Fluticasone STADA
Hungary:
Azelastine/Fluticasone Stada 137 mikrogramm/50 mikrogramm szuszpenziós orrspray
Italy:
Azelastina e Fluticasone EG
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.